Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
European Commission
About
Opens for applications on 2026-10-29. A European Commission call for proposals. Expected Outcome: This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Developing and using new tools, technologies and digital solutions for a healthy society”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to all the following expected outcomes: Clinical researchers and developers have access to novel predictive biomarkers to guide a more accurate assessment of disease progression and treatment response and tackle the unmet clinical needs of non-communicable chronic diseases. Clinicians and healthcare professionals use clinically validated predictive biomarkers for implementing more effective clinical research and personalised medicine with better health outcomes in chronic non-communicable diseases. Key stakeholders have access to trustworthy Artificial Intelligence (AI) tools to guide the development of multimodal predictive biomarkers of higher accuracy and clinical value when compared to the established practice. The citizens benefit of better health outcomes thanks to improved clinical guidelines and the implementation of ef
Who can apply
Usually organisations in EU member states and associated countries, often in a consortium. Some calls are open to partners from other countries. Check the call conditions.
Best for
- Researchers
- NGOs
- Founders
- Location
- Europe
- Cost
- Free to apply
- Organizer
- European Commission
- 43108390
- eu funding